Navigation Links
Novo Nordisk introduces HemaGo, a mobile application to track hemophilia treatment, bleeding episodes and life events
Date:11/27/2012

PRINCETON, N.J., Nov. 27, 2012 /PRNewswire/ -- Novo Nordisk announced today the introduction of HemaGo, a mobile application (app) to help individuals with hemophilia and their caregivers monitor the details of treatment, including medications, dosing, bleed information and the impact of hemophilia on life events.  

The app offers multiple profiles so that more than one family member can use the tool.  HemaGo helps them track multiple medications, set reminders for treatment or doctor's appointments.  As well, HemaGo can be used to record factor usage and reason for infusion; the type, location and duration of bleeding events; and pain scores, including the impact of the bleeding episode on the individual's participation in work or school. 

"For the first time, individuals can track virtually every aspect of living with a bleeding disorder, regardless of their medication or disorder," said Eddie Williams, Corporate Vice President, Biopharmaceuticals.  "Thanks to input from members in the hemophilia community, we've created a first in class offering that provides benefits to all hemophilia patients and healthcare professionals."

Information from the HemaGo app syncs to Novo Nordisk's Changing Possibilities in Hemophilia website (www.changingpossibilities-us.com).  At the site, individuals have access to comprehensive reporting features, including treatment logs, bleed logs, and quality of life reports.  This information may be shared with the individual's healthcare team, including their hemophilia treatment center and home healthcare company. 

Novo Nordisk does not have access to patient-specific information.  The company's access is restricted to generic information ("de-identified") in which the data has been stripped so that the individual source cannot be identified, in accordance with Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules. 

Novo Nordisk is working with the American Thrombosis and Hemostasis Network (ATHN) to enable patients who choose the option to link their diary data with their other medical records on ATHN's national database of bleeding disorder treatment information. 

HemaGo was developed with the participation of Novo Nordisk's Consumer Council, which is comprised of bleeding disorder community members.

HemaGo is available for free download at www.changingpossibilities-us.com.  The Android version is expected to be available in November 2012.  The app's tools are also available from the website for individuals who do not have a mobile device.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.

iPhone and iPad are registered trademarks of Apple Inc.

Android is a registered trademark of Google.

 


'/>"/>
SOURCE Novo Nordisk
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against Diabetes
2. Novo Nordisk Supports Three Houston-Based Organizations In Fight Against Diabetes
3. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
4. Anthro Introduces Steves Station Curve at RSNA 2012
5. Filtrona Porous Technologies Introduces New Medical-Grade Foams And Unique Fiber Products For Clean Environments At MEDICA / COMPAMED Trade Fair
6. Richard Wolf Introduces the Smallest Bipolar Resectoscope on the Market
7. Elekta Introduces MOSAIQ Connectivity for its microSelectron Digital Brachytherapy Afterloader at ASTRO Annual Meeting
8. InkSure Introduces FDA Approved High Security Taggants for Direct Food Contact
9. Dynatronics Introduces New SolarisPlus Line of Therapy Products
10. RNL BIO, a South Korean adult stem cell firm, introduces its autologous stem cell therapeutics in Turkey to treat patients with various intractable diseases
11. Olympus Introduces the Worlds First and Only Monopolar, Disposable Tonsil Adenoid Debrider (DTAD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO ... quarter 2017 operating results on Monday, August 7, 2017 ... at 5:00 p.m. ET. ... live broadcast of the conference call by dialing 877-201-0168 ... 51641230 approximately 15 minutes prior to the call. A ...
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/14/2017)... -- It should come as no surprise to anyone that ... midst of a crippling opioid epidemic. According to the ... overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... from 2001 to 2015". During this time, the prescription rate ... drawing a compelling link between prescription and eventual addiction. The ...
Breaking Medicine Technology:
(Date:7/24/2017)... Los Angeles, CA (PRWEB) , ... July 24, 2017 , ... ... that will spotlight doctors and the cosmetic surgeries they perform on a daily basis. ... in performing the cosmetic surgery procedures they specialize in at their practices. , ...
(Date:7/24/2017)... ... 2017 , ... Peruvian Ayahuasca retreat, East West Lodge, announced ... and divided between two full-time university students enrolled in U.S. or Canadian accredited ... apply for the scholarship, students are asked to submit an essay between 750 ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care product, ... of the leading causes of long term skin conditions, including cancer. In ...
(Date:7/24/2017)... ... 24, 2017 , ... Anyone who uses scales know they have limits; a ... using that same scale to dispense medication. The first example is an issue of ... why it is important to have the right balance for the process. METTLER TOLEDO’s ...
(Date:7/24/2017)... TX (PRWEB) , ... July 24, 2017 , ... Paul ... of the nation’s top level plastic surgeons, invited to attend Allergan’s recent meeting with ... 10 most valued companies in the world, Allergan is bringing a newly defined structure ...
Breaking Medicine News(10 mins):